Cambridge Nutritional Sciences plc
CNSL.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | £4 | £4 | £4 | £5 |
| % Growth | -7.9% | 1.5% | -14.6% | – |
| Cost of Goods Sold | £1 | £2 | £2 | £2 |
| Gross Profit | £2 | £3 | £2 | £3 |
| % Margin | 61.8% | 60.1% | 60.1% | 56.5% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £3 | £3 | £3 | £3 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £3 | £3 | £3 | £3 |
| Operating Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -10.2% | -11.8% | -4.3% | -3.6% |
| Other Income/Exp. Net | -£0 | £2 | -£0 | £0 |
| Pre-Tax Income | -£0 | £2 | -£0 | -£0 |
| Tax Expense | £0 | £0 | £0 | -£0 |
| Net Income | -£0 | £2 | -£0 | £0 |
| % Margin | -10.3% | 42% | -4.7% | 7.6% |
| EPS | -0.002 | 0.007 | -0.001 | 0.002 |
| % Growth | -123% | 1,025% | -150% | – |
| EPS Diluted | -0.002 | 0.007 | -0.001 | 0.002 |
| Weighted Avg Shares Out | 238 | 238 | 238 | 238 |
| Weighted Avg Shares Out Dil | 238 | 238 | 238 | 238 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | £2 | £0 | £0 |
| % Margin | -1.7% | 49.5% | 2.9% | 5.9% |